Onca Bio is a biotechnology company discovering the next generation of peptide therapeutics and other small biologics
Onca Bio is a biotechnology company discovering the next generation of peptide therapeutics and other small biologics. We specialize in building and screening custom libraries carefully designed to deliver hits that are not only potent binders but also suitable lead compounds. This approach accelerates the path from early discovery to drug-ready leads across high-impact areas such as targeted cancer therapies, delivery technologies, oral bioavailability, and AI-enabled drug discovery. Backed by a multidisciplinary founding team spanning chemistry, biology, and computation, Onca Bio is building the foundation for the next wave of medicines.